Henry Schein Stock Is Trading Higher On Beating On Q1 Earnings, Raised EPS Guidance

  • Henry Schein Inc HSIC raised its 2021 guidance after reporting first-quarter earnings, which topped the consensus.
  • It posted an adjusted EPS of $1.24 ahead of the consensus of $0.85. Reported EPS came in at $1.16 compared to $0.91 a year ago.
  • Net sales of $2.9 billion were well above the consensus of $2.8 billion, increased 20.4% Y/Y, and included 14.9% internal growth in local currencies, 3.3% growth from acquisitions, and 2.2% growth related to foreign currency exchange.
  • Its medical segment registered global sales growth of 24% to $993 million, while its dental business’ revenues increased 21.3% to $1.8 billion.
  • Guidance: Henry Schein raised its FY21 financial guidance, setting its projected adjusted EPS at $3.70 or above, versus analyst consensus of $3.72.
  • Price Action: HSIC shares are up 6.20% at $78.60 during the market trading session on the last check Tuesday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: BiotechEarningsNewsGuidanceHealth CareGeneralBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!